CSW insider files Form 4: 1,000-share sale; awards detailed
Rhea-AI Filing Summary
CSW Industrials (CSW) reported an insider transaction by its Chairman, President & CEO, who is also a Director. On 10/30/2025, the reporting person sold 1,000 shares of common stock at $250 per share under a pre‑arranged Rule 10b5‑1 trading plan. Following the sale, the filer beneficially owns 66,493 shares directly and 3,219 shares indirectly through an ESOP.
The filer also reports equity awards: performance rights covering 8,004, 8,236, 12,422, and 18,372 shares that vest based on relative total shareholder return over performance cycles ending March 31, 2026–2028, and 19,685 restricted stock units that vest upon the recruitment and first employment anniversary of a successor CEO, as specified.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: small 10b5‑1 sale; sizable awards outstanding.
The CEO and Director of CSW Industrials reported an open‑market sale coded “S” of 1,000 shares at $250 on 10/30/2025 pursuant to a Rule 10b5‑1 plan. After the trade, direct beneficial ownership stands at 66,493 shares, with 3,219 shares held indirectly via an ESOP.
Derivative holdings include performance rights tied to relative total shareholder return versus the Russell 2000 over cycles ending on Mar 31, 2026–2028 (blocks of 8,004, 8,236, 12,422, 18,372 shares) and 19,685 RSUs that vest upon milestones related to recruiting and the first employment anniversary of a successor CEO. Settlement may be in cash or shares at the issuer’s discretion.
As a routine insider filing, market impact is typically limited; actual effects depend on future vesting outcomes and holder decisions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,000 | $250.00 | $250K |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025 and ending on March 31, 2028 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
